Jörg Wegener

5PUBLICATIONS
23CO-AUTHORS
Biologically active moleculesRegenerative medicine (incl. stem cells)Molecular medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 06, 2025
Multitargeted Caffeic Acid Derivatives Inhibit Cardiac RyR2- and NaV1.5- Channels but Stimulate SERCA2a Pump Activity.

Gyuzel Y Mitronova, Christine Quentin, Vladimir N Belov

|Jan 05, 2024
Noninvasive analysis of contractility during identical maturations revealed two phenotypes in ventricular but not in atrial iPSC-CM.

Marcel Rapöhn, Lukas Cyganek, Niels Voigt

|Nov 27, 2023
A dual-targeted drug inhibits cardiac ryanodine receptor Ca2+ leak but activates SERCA2a Ca2+ uptake.

Jörg W Wegener, Gyuzel Y Mitronova, Lina ElShareif

|Nov 22, 2023
1,4-Benzothiazepines with Cyclopropanol Groups and Their Structural Analogues Exhibit Both RyR2-Stabilizing and SERCA2a-Stimulating Activities.

Gyuzel Y Mitronova, Christine Quentin, Vladimir N Belov

|Jul 13, 2022
TRPM4 inhibition by meclofenamate suppresses Ca2+-dependent triggered arrhythmias.

Frone Vandewiele, Andy Pironet, Griet Jacobs

Pageof 1